Cargando…
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164054/ https://www.ncbi.nlm.nih.gov/pubmed/34052830 http://dx.doi.org/10.1038/s41392-021-00628-x |
| _version_ | 1783701033211396096 |
|---|---|
| author | Sun, Qi Ye, Fei Liang, Hao Liu, Hongbo Li, Chunmei Lu, Roujian Huang, Baoying Zhao, Li Tan, Wenjie Lai, Luhua |
| author_facet | Sun, Qi Ye, Fei Liang, Hao Liu, Hongbo Li, Chunmei Lu, Roujian Huang, Baoying Zhao, Li Tan, Wenjie Lai, Luhua |
| author_sort | Sun, Qi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8164054 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81640542021-06-01 Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease Sun, Qi Ye, Fei Liang, Hao Liu, Hongbo Li, Chunmei Lu, Roujian Huang, Baoying Zhao, Li Tan, Wenjie Lai, Luhua Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-05-29 /pmc/articles/PMC8164054/ /pubmed/34052830 http://dx.doi.org/10.1038/s41392-021-00628-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Sun, Qi Ye, Fei Liang, Hao Liu, Hongbo Li, Chunmei Lu, Roujian Huang, Baoying Zhao, Li Tan, Wenjie Lai, Luhua Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease |
| title | Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease |
| title_full | Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease |
| title_fullStr | Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease |
| title_full_unstemmed | Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease |
| title_short | Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease |
| title_sort | bardoxolone and bardoxolone methyl, two nrf2 activators in clinical trials, inhibit sars-cov-2 replication and its 3c-like protease |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164054/ https://www.ncbi.nlm.nih.gov/pubmed/34052830 http://dx.doi.org/10.1038/s41392-021-00628-x |
| work_keys_str_mv | AT sunqi bardoxoloneandbardoxolonemethyltwonrf2activatorsinclinicaltrialsinhibitsarscov2replicationandits3clikeprotease AT yefei bardoxoloneandbardoxolonemethyltwonrf2activatorsinclinicaltrialsinhibitsarscov2replicationandits3clikeprotease AT lianghao bardoxoloneandbardoxolonemethyltwonrf2activatorsinclinicaltrialsinhibitsarscov2replicationandits3clikeprotease AT liuhongbo bardoxoloneandbardoxolonemethyltwonrf2activatorsinclinicaltrialsinhibitsarscov2replicationandits3clikeprotease AT lichunmei bardoxoloneandbardoxolonemethyltwonrf2activatorsinclinicaltrialsinhibitsarscov2replicationandits3clikeprotease AT luroujian bardoxoloneandbardoxolonemethyltwonrf2activatorsinclinicaltrialsinhibitsarscov2replicationandits3clikeprotease AT huangbaoying bardoxoloneandbardoxolonemethyltwonrf2activatorsinclinicaltrialsinhibitsarscov2replicationandits3clikeprotease AT zhaoli bardoxoloneandbardoxolonemethyltwonrf2activatorsinclinicaltrialsinhibitsarscov2replicationandits3clikeprotease AT tanwenjie bardoxoloneandbardoxolonemethyltwonrf2activatorsinclinicaltrialsinhibitsarscov2replicationandits3clikeprotease AT lailuhua bardoxoloneandbardoxolonemethyltwonrf2activatorsinclinicaltrialsinhibitsarscov2replicationandits3clikeprotease |